DK3043777T3 - Sublingual buprenorphinspray - Google Patents
Sublingual buprenorphinspray Download PDFInfo
- Publication number
- DK3043777T3 DK3043777T3 DK14843903.7T DK14843903T DK3043777T3 DK 3043777 T3 DK3043777 T3 DK 3043777T3 DK 14843903 T DK14843903 T DK 14843903T DK 3043777 T3 DK3043777 T3 DK 3043777T3
- Authority
- DK
- Denmark
- Prior art keywords
- buprenorphinspray
- sublingual
- sublingual buprenorphinspray
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361875837P | 2013-09-10 | 2013-09-10 | |
PCT/US2014/052699 WO2015038327A1 (en) | 2013-09-10 | 2014-08-26 | Sublingual buprenorphine spray |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3043777T3 true DK3043777T3 (da) | 2020-07-20 |
Family
ID=52625856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14843903.7T DK3043777T3 (da) | 2013-09-10 | 2014-08-26 | Sublingual buprenorphinspray |
Country Status (8)
Country | Link |
---|---|
US (1) | US9216175B2 (da) |
EP (1) | EP3043777B1 (da) |
JP (1) | JP2016529328A (da) |
CA (1) | CA2923811C (da) |
DK (1) | DK3043777T3 (da) |
ES (1) | ES2802976T3 (da) |
HK (1) | HK1225653A1 (da) |
WO (1) | WO2015038327A1 (da) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK3125893T3 (da) | 2014-04-04 | 2023-11-20 | Intra Cellular Therapies Inc | Deutererede heterocyklus-fusionerede gamma-carboliner som antagonister af 5-ht2a-receptorer |
US10617686B2 (en) * | 2014-07-08 | 2020-04-14 | Hikma Pharmaceuticals Usa Inc. | Liquid naloxone spray |
US10722510B2 (en) * | 2014-07-08 | 2020-07-28 | Hikma Pharmaceuticals Usa Inc. | Liquid naloxone spray |
WO2016007245A1 (en) * | 2014-07-08 | 2016-01-14 | Insys Pharma, Inc. | Sublingual naloxone spray |
DK3277283T3 (da) * | 2015-04-03 | 2021-04-12 | Benuvia Therapeutics Llc | Sublinguale sildenafilsprayformuerlinger |
US20160296498A1 (en) * | 2015-04-09 | 2016-10-13 | Insys Development Company, Inc. | Ketorolac Sublingual Spray Formulations |
JP2018531964A (ja) * | 2015-10-27 | 2018-11-01 | インシス・ディベロップメント・カンパニー・インコーポレイテッド | 液体ブプレノルフィン製剤 |
WO2017132408A1 (en) | 2016-01-26 | 2017-08-03 | Intra-Cellular Therapies, Inc. | Organic compounds |
PT3407889T (pt) | 2016-03-25 | 2021-07-14 | Intra Cellular Therapies Inc | Compostos orgânicos e a sua utilização no tratamento ou prevenção de distúrbios do sistema nervoso central |
EP3500261A4 (en) * | 2016-08-17 | 2020-05-06 | Hikma Pharmaceuticals USA Inc. | LIQUID NALOXONE SPRAYING |
WO2018126140A1 (en) | 2016-12-29 | 2018-07-05 | Intra-Cellular Therapies, Inc. | Organic compounds |
WO2018126143A1 (en) | 2016-12-29 | 2018-07-05 | Intra-Cellular Therapies, Inc. | Organic compounds |
IL268970B2 (en) | 2017-03-24 | 2023-12-01 | Intra Cellular Therapies Inc | Oral preparations of heterocyclic gamma carboline derivatives fused for absorption through mucous membranes |
WO2019026085A1 (en) * | 2017-08-04 | 2019-02-07 | Alkem Laboratories Ltd. | SUBLINGUAL FILM COMPOSITION |
US20180193332A1 (en) * | 2017-10-09 | 2018-07-12 | Adapt Pharma Operations Limited | Low-temperature stable opioid antagonist solutions |
CA3108558A1 (en) | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel methods |
WO2020047407A1 (en) | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel methods |
CA3142247A1 (en) * | 2019-07-01 | 2021-01-07 | Oculis SA | Method for stabilizing the ph of an aqueous composition comprising a drug |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6512010B1 (en) * | 1996-07-15 | 2003-01-28 | Alza Corporation | Formulations for the administration of fluoxetine |
US6413496B1 (en) | 1996-12-04 | 2002-07-02 | Biogland Ireland (R&D) Limited | Pharmaceutical compositions and devices for their administration |
IT1302682B1 (it) | 1998-10-16 | 2000-09-29 | Formenti Farmaceutici Spa | Composizioni farmaceutiche orali contenenti buprenorfina |
KR100383252B1 (ko) * | 1998-12-17 | 2003-07-16 | 주식회사 삼양사 | 부프레놀핀을함유하는경피투여조성물및이를포함하는패취 |
AR031682A1 (es) * | 1999-11-19 | 2003-10-01 | Reckitt Benckiser Helthcare Uk | Composiciones farmaceuticas |
WO2001097780A2 (en) | 2000-06-22 | 2001-12-27 | Pharmasol Ltd | Pharmaceutical compositions comprising an opioid analgesic |
EP1418862A4 (en) | 2001-06-29 | 2010-06-09 | Leon J Lewandowski | INDIVIDUALIZED SEARCH THERAPY |
US7666876B2 (en) * | 2002-03-19 | 2010-02-23 | Vernalis (R&D) Limited | Buprenorphine formulations for intranasal delivery |
US6946150B2 (en) | 2002-08-14 | 2005-09-20 | Gw Pharma Limited | Pharmaceutical formulation |
AU2003265511A1 (en) * | 2002-08-21 | 2004-03-11 | Pharmacia Corporation | Injectable pharmaceutical suspension in a two-chamber vial |
DE60329515D1 (de) * | 2002-10-25 | 2009-11-12 | Euro Celtique Sa | Analoga und prodrugs von buprenorphin |
WO2004071491A1 (en) | 2003-02-04 | 2004-08-26 | Chrysalis Technologies Incorporated | Aerosol formulations and aerosol delivery of buspirone, buprenorphine, triazolam, cyclobenzaprine and zolpidem |
WO2006105205A1 (en) | 2005-03-29 | 2006-10-05 | University Of Kentucky Research Foundation | Sublingual spray for the treatment of pain |
BRPI0619806A2 (pt) | 2005-12-13 | 2011-10-18 | Biodelivery Sciences Int Inc | dispositivo para fornecimento de fármacos transmucosal resistente ao abuso |
AU2007208229B2 (en) | 2006-01-25 | 2009-11-05 | Insys Therapeutics Inc. | Sublingual fentanyl spray |
EP2015632B1 (en) | 2006-04-19 | 2015-12-02 | Mist Pharmaceuticals, LLC | Stable hydroalcoholic oral spray formulations and methods |
US20100233257A1 (en) * | 2006-06-09 | 2010-09-16 | Ethypharm | Low dose sublingual tablets of opioid analgesics and preparation process |
HUE027395T2 (hu) | 2006-07-21 | 2016-10-28 | Biodelivery Sciences Int Inc | Eszközök nyálkahártyán keresztül történõ bejuttatására, javított felszívódással |
EP1897543A1 (en) | 2006-08-30 | 2008-03-12 | Euro-Celtique S.A. | Buprenorphine- wafer for drug substitution therapy |
US20090270438A1 (en) | 2006-10-18 | 2009-10-29 | Clive Booles | Novel compositions and formulations |
GB2461681A (en) * | 2008-04-17 | 2010-01-13 | Pharmasol Ltd | Buprenorphine liquid spray formulation with solvent and antioxidant |
GB2447014A (en) | 2007-03-01 | 2008-09-03 | Reckitt Benckiser Healthcare | Analgesic composition comprising a specific ratio of buprenorphine and naltrexone |
AU2008282743B2 (en) * | 2007-08-02 | 2012-11-29 | Insys Therapeutics Inc. | Sublingual fentanyl spray |
EP2254561A2 (en) | 2008-03-26 | 2010-12-01 | AllTranz Inc. | Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists |
CA2728912C (en) | 2008-06-23 | 2018-04-10 | Biodelivery Sciences International, Inc. | Multidirectional mucosal delivery devices and methods of use |
US8475832B2 (en) * | 2009-08-07 | 2013-07-02 | Rb Pharmaceuticals Limited | Sublingual and buccal film compositions |
CA2795156C (en) | 2010-04-02 | 2019-05-14 | Alltranz Inc. | Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugs |
-
2014
- 2014-08-26 EP EP14843903.7A patent/EP3043777B1/en active Active
- 2014-08-26 CA CA2923811A patent/CA2923811C/en active Active
- 2014-08-26 JP JP2016541991A patent/JP2016529328A/ja active Pending
- 2014-08-26 ES ES14843903T patent/ES2802976T3/es active Active
- 2014-08-26 WO PCT/US2014/052699 patent/WO2015038327A1/en active Application Filing
- 2014-08-26 US US14/469,063 patent/US9216175B2/en active Active
- 2014-08-26 DK DK14843903.7T patent/DK3043777T3/da active
-
2016
- 2016-12-13 HK HK16114179A patent/HK1225653A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HK1225653A1 (zh) | 2017-09-15 |
EP3043777A4 (en) | 2017-08-02 |
US20150071971A1 (en) | 2015-03-12 |
JP2016529328A (ja) | 2016-09-23 |
WO2015038327A1 (en) | 2015-03-19 |
US9216175B2 (en) | 2015-12-22 |
EP3043777B1 (en) | 2020-04-22 |
CA2923811A1 (en) | 2015-03-19 |
EP3043777A1 (en) | 2016-07-20 |
ES2802976T3 (es) | 2021-01-22 |
CA2923811C (en) | 2021-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3342773T3 (da) | Syk-hæmmere | |
DK3613453T3 (da) | Fordamper | |
UY4298S (es) | Carcasa | |
DK3043777T3 (da) | Sublingual buprenorphinspray | |
DK3077047T3 (da) | Aramcholsalte | |
DK3060460T3 (da) | Saddel | |
DK3027598T3 (da) | Oxoquinazolinyl-butanamidderivater | |
DK2956698T5 (da) | Bindestrimler | |
DK3052081T3 (da) | Pastil | |
DK2946640T3 (da) | Langmuir-probe | |
DK3071227T3 (da) | Fiskevaccine | |
DE102013106534B8 (de) | Chromatographiepipettenspitze | |
DE112014001252A5 (de) | Aufbissschiene | |
DK2981168T3 (da) | Laminitiskile | |
DK3086679T3 (da) | Sportssko | |
FI10343U1 (fi) | Mittateippi | |
FI10138U1 (fi) | Kelkkateltta | |
ES1078715Y (es) | Mosquitera | |
DE112014005422A5 (de) | Friktionsfalschdrallaggregat | |
BR112016000501A2 (pt) | Nalador | |
UY4342S (es) | Carcasa | |
FI10396U1 (fi) | Tielana | |
ES1100380Y (es) | Trompo | |
ES1093505Y (es) | Aerociclo | |
ES1096481Y (es) | Ecofregona |